Key facts
- This page summarizes David Thomson's Form 4 filing for MANNKIND CORP (MNKD).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 May 2024, 21:00.
David Thomson - 17 May 2024 Form 4 Insider Report for MANNKIND CORP (MNKD)
- Reporting relationship
- EVP Genl Counsel & Secretary
- Issuer ticker
- MNKD
- Reported as of
- 17 May 2024
- Net transaction value
- -$179,877
- SEC form
- 4
- Accepted by SEC
- 21 May 2024, 21:00:31 UTC
- Prior SEC filing
- 17 May 2024
- Next SEC filing
- 17 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Thomson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Thomson filed Form 4 for MANNKIND CORP (MNKD) on 21 May 2024.
Change
- Previous filing in this sequence was filed on 17 May 2024.
- Current net transaction value: -$179,877.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MNKD
transaction
Common Stock, $0.01 Par Value
Award
- Transaction value
- $355,358
- Shares
- +77,420
- Change %
- +8.5%
- Price
- $4.59
- Shares after
- 989,866
- Date
- 17 May 2024
- Ownership
- Direct
- Footnotes
- F1
MNKD
transaction
Common Stock, $0.01 Par Value
Tax liability
- Transaction value
- $393,808
- Shares
- -85,797
- Change %
- -8.7%
- Price
- $4.59
- Shares after
- 904,069
- Date
- 17 May 2024
- Ownership
- Direct
- Footnotes
- F2
MNKD
transaction
Common Stock, $0.01 Par Value
Tax liability
- Transaction value
- $31,744
- Shares
- -6,916
- Change %
- -0.76%
- Price
- $4.59
- Shares after
- 897,153
- Date
- 18 May 2024
- Ownership
- Direct
- Footnotes
- F2
MNKD
transaction
Common Stock, $0.01 Par Value
Sale
- Transaction value
- $109,682
- Shares
- -23,537
- Change %
- -2.6%
- Price
- $4.66
- Shares after
- 873,616
- Date
- 21 May 2024
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
A previously reported restricted stock unit award granted on May 18, 2021 vested on May 17, 2024 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on May 17, 2024 was not less than the closing price on May 17, 2021 and (ii) MannKind's total shareholder return (TSR) over the period from May 18, 2021 to May 17, 2024 was at the 74.5th percentile of the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period. As a result, the performance objective was achieved at 198% of target, resulting in a total share delivery of 156,420 shares. The acquisition of 79,000 shares pursuant to the restricted stock award was reported in Table I of the Form 4 filed by the Reporting Person on May 18, 2021.
Footnote F2
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Footnote F3
Transaction occurred pursuant to Rule 10b5-1 Plan established September 5, 2023.